Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
09/2014
09/18/2014WO2014142995A1 Compositions and methods including leelamine and arachidonyl trifluoromethyl ketone relating to treatment of cancer
09/18/2014WO2014142705A1 A cytokine-containing drug having an antiviral, antimicrobial, immunomodulatory and anti-inflammatory effect for treating and prophylaxis of infectious diseases
09/18/2014WO2014142675A1 Nanofibre and bioactive compositions and related methods
09/18/2014WO2014142616A1 Mosapride sustained-release preparation for providing pharmacological clinical effects with once-a-day administration
09/18/2014WO2014142607A1 Pharmaceutical combination drug
09/18/2014WO2014142146A1 Therapeutic agent for meibomian dysfunction
09/18/2014WO2014142135A1 Micro-needle patch
09/18/2014WO2014141289A1 Photo - chemo composition on the basis of microcapsules with a core -shell structure
09/18/2014WO2014141288A1 The art, method, manner, process and system of a nano-biomineral for multi-modal contrast imaging and drug delivery
09/18/2014WO2014141287A1 The art, method, manner, process and system of multifunctional nanobiomaterial for molecular imaging and drug- delivery
09/18/2014WO2014141280A1 Methods, compositions and devices for treatment of motor and depression symptoms associated with parkinson's disease
09/18/2014WO2014141265A1 Inhibition of neurodegenerative disease by grape seed extract, green tea extract and probiotic bacteria
09/18/2014WO2014141135A1 Respirable agglomerates of porous carrier particles and micronized drug
09/18/2014WO2014141069A1 Deamorphization of spray-dried formulations via spray-blending
09/18/2014WO2014140991A1 Enteric coating for soft capsule
09/18/2014WO2014140925A2 Topical compositions and methods of treatment of topical disorders
09/18/2014WO2014140867A2 Compositions and methods for administration to subjects with dysphagia
09/18/2014WO2014140670A1 Liposome formulation and manufacture
09/18/2014WO2014140645A1 Stable aqueous formulations of adenovirus vectors
09/18/2014WO2014140549A1 Cell delivery medium
09/18/2014WO2014140524A1 Pharmaceutical composition for the treatment of fungal infections
09/18/2014WO2014140507A1 Pharmaceutical composition for the treatment of fungal infections
09/18/2014WO2014140482A1 Coating composition based on food colouring agents
09/18/2014WO2014140475A1 Film-forming composition and use thereof for the treatment of skin disorders
09/18/2014WO2014140411A1 Encapsulated composition for binding aldehydes in the stomach
09/18/2014WO2014140410A1 Composition for oral administration for binding aldehydes in the gastrointestinal tract
09/18/2014WO2014140402A1 Use of derivatives with c-o-p bonds in patients with renal failure
09/18/2014WO2014140268A1 Solid lipid nanoparticles (ii)
09/18/2014WO2014140231A1 Abuse resistant capsule
09/18/2014WO2014140213A1 Taxoid - purification principle for liquid excipients
09/18/2014WO2014140159A1 Dosage form comprising crizotinib
09/18/2014WO2014140095A1 Injectable morphine formulations
09/18/2014WO2014139836A1 Pharmaceutical compositions comprising imatinib
09/18/2014WO2014139803A1 Process and apparatus for metering a plasticized formulation
09/18/2014WO2014139677A1 Parenteral formulation of fluoroquinolone antibacterial agent and method for preparation thereof
09/18/2014WO2014139657A1 Pharmaceutical composition containing an oxazolidinone antibacterial agent and method for the preparation thereof
09/18/2014WO2014139329A1 Spray-dried powder comprising vancomycin hydrochloride, and industrial manufacturing method thereof
09/18/2014WO2014139282A1 Pharmaceutical compositions for treating cancer of genital system and preparation method therefor
09/18/2014WO2014139168A1 Preparation process of polymeric microspheres
09/18/2014WO2014138975A1 Preparation and method for use in the treatment of respiratory diseases
09/18/2014WO2014138930A1 Biophotonic materials and uses thereof
09/18/2014US20140276483 Transdermal methylphenidate compositions with acrylic block copolymers
09/18/2014US20140276480 Biomolecular wearable apparatus
09/18/2014US20140276479 Transdermal drug delivery system with overlay
09/18/2014US20140276478 Compositions and methods for transdermal delivery of tertiary amine drugs
09/18/2014US20140275285 Metadichol® liquid and gel nanoparticle formulations
09/18/2014US20140275283 Product and Method for Improving Bioavailability of Therapeutic Compounds
09/18/2014US20140275278 Pharmaceutical composition of s-ketamine hydrochloride
09/18/2014US20140275265 Therapeutic cream for application to skin
09/18/2014US20140275263 Microemulsion Topical Delivery Platform
09/18/2014US20140275261 Diclofenac parenteral compositions
09/18/2014US20140275260 Preparation Of Stable Pharmaceutical Dosage Forms
09/18/2014US20140275256 Transepithelial Methods Of Using Gamma Aminobutyric Acid Compositions For Pain Relief
09/18/2014US20140275246 Racecadotril lipid compositions
09/18/2014US20140275242 Hot melt granulation formulations of poorly water-soluble active agents
09/18/2014US20140275202 Injectable ropinirole compositions and methods for making and using same
09/18/2014US20140275197 Alpha-2 adrenergic agonist for treating intraocular pressure and ocular diseases through intravitreal and intracameral routes
09/18/2014US20140275170 Taste masking of anesthetics and analgesics
09/18/2014US20140275149 Abuse deterrent compositions and methods of use
09/18/2014US20140275148 Orally administrable, self-supporting dissolving film dosage forms
09/18/2014US20140275144 Morphine formulations
09/18/2014US20140275143 Compositions Comprising An Opioid And An Additional Active Pharmaceutical Ingredient For Rapid Onset And Extended Duration Of Analgesia That May Be Administered Without Regard To Food
09/18/2014US20140275122 Voriconazole Formulations
09/18/2014US20140275109 Methods for Administering Aripiprazole
09/18/2014US20140275091 Ocular formulations comprising geranylgeranylacetone derivatives for intraocular delivery
09/18/2014US20140274997 Cephalosporin pharmaceutical compositions
09/18/2014US20140274996 Tazobactam and ceftolozane antibiotic compositions
09/18/2014US20140274991 Ceftolozane pharmaceutical compositions
09/18/2014US20140274982 Topical compositions of flunisolide and methods of treatment
09/18/2014US20140274981 Pharmaceutical composition of s-ketamine hydrochloride
09/18/2014US20140274929 Stealth Polymeric Particles For Delivery Of Bioactive Or Diagnostic Agents
09/18/2014US20140274881 Biodegradable therapeutic nanoparticles containing an antimicrobial agent
09/18/2014US20140272101 Microarray for delivery of therapeutic agent, methods of use, and methods of making
09/18/2014US20140272100 Processes for coating a carrier with microparticles
09/18/2014US20140272099 Method for Producing and Monitoring Oral Active Ingredient Films
09/18/2014US20140271931 Anti-Acne Topical Films
09/18/2014US20140271921 Pharmaceutical composition
09/18/2014US20140271903 Use of thermo-sensitive gel for controlled delivery of alk-5 inhibitors to the eye and related methods
09/18/2014US20140271902 Particulate hyaluronic acid formulations for cellular delivery of bioactive agents
09/18/2014US20140271901 Management of Tractional Membranes
09/18/2014US20140271899 Method of enhancing the biodistribution and tissue targeting properties of therapeutic ceco2 particles via nano-encapsulation and coating
09/18/2014US20140271898 Abuse deterrent compositions and methods of use
09/18/2014US20140271897 Compositions, methods and devices for local drug delivery
09/18/2014US20140271896 Tamper resistant pharmaceutical formulations
09/18/2014US20140271895 Polymorph Compositions, Methods of Making, and Uses Thereof
09/18/2014US20140271894 Matrix-incorporated fluorescent porous silica particles for drug delivery
09/18/2014US20140271893 Coated phenylephrine particles and use thereof in pharmaceutical formulations
09/18/2014US20140271890 Controlled-release pharmaceutical composition
09/18/2014US20140271889 Multifunctional metal nanoparticles having a polydopamine-based surface and methods of making and using the same
09/18/2014US20140271888 Diketopiperazine microparticles with defined specific surface areas
09/18/2014US20140271887 Antiemetic extended release solid dosage forms
09/18/2014US20140271886 Bioerodible Silicon-Based Compositions for Delivery of Therapeutic Agents
09/18/2014US20140271885 Copolymers for stable micelle formulations
09/18/2014US20140271884 High-loading nanoparticle-based formulation for water-insoluble steroids
09/18/2014US20140271883 Curcuminoids and metabolites thereof for treating allergic nasal conditions
09/18/2014US20140271876 Ophthalmic formulations
09/18/2014US20140271875 Compositions including encapsulated isotretinoin and methods for use thereof
09/18/2014US20140271871 Methods and compositions for treating pulmonary hypertension
09/18/2014US20140271869 High drug load buprenorphine microspheres and method of producing same
09/18/2014US20140271867 Film delivery system for active ingredients
1 ... 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 ... 2991